Pulmocide Company
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
Technology:
AgeTech Companies
Industry:
Deep diagnostics
Headquarters:
London, England, United Kingdom
Founded Date:
2013-01-01
Employees Number:
11-50
Funding Status:
Late Stage Venture
Total Funding:
$153,460,089.00
Estimated Revenue:
$1M to $10M
Last Funding Type:
Grant
Register and Claim Ownership